{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:35:54Z","timestamp":1791329754352,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.hoc.2004.04.005","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:30Z","timestamp":1113821610000},"page":"915-926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of auto- and allotransplantation in B-cell chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"18","author":[{"given":"Emili","family":"Montserrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2004.04.005_BIB1","series-title":"SEER cancer statistics review, 1993\u20131997","year":"2000"},{"key":"10.1016\/j.hoc.2004.04.005_BIB2","series-title":"Hematology (American Society of Hematology Education Program Book)","first-page":"153","article-title":"Biology and treatment of chronic lymphocytic leukemia","author":"Keating","year":"2003"},{"key":"10.1016\/j.hoc.2004.04.005_BIB3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.thj.6200139","article-title":"Classical and new prognostic factors in chronic lymphocytic leukemia: where to now?","volume":"3","author":"Montserrat","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.hoc.2004.04.005_BIB4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood-2003-07-2281","article-title":"Prognosis at diagnosis: integrating molecular biology insights into practice for patients with chronic lymphocytic leukaemia","volume":"103","author":"Shanafelt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.04.005_BIB9","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","article-title":"ZAP-70 expression and prognosis in chronic lymphocytic leukemia","volume":"363","author":"Orchad","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.04.005_BIB11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2003-05-1449","article-title":"Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia","volume":"103","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB12","first-page":"SS1090","article-title":"Autologous stem cell transplantation for CLL: parameters predicting feasibility and outcome[abstract]","volume":"84","author":"Dreger","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2004.04.005_BIB13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.leu.2403190","article-title":"Successful CD34+ cell mobilization by intermediate-dose Ara C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H","volume":"18","author":"Montillo","year":"2004","journal-title":"Leukemia"},{"issue":"Suppl I","key":"10.1016\/j.hoc.2004.04.005_BIB14","first-page":"397a","article-title":"Autologous stem-cell transplantation (ASCT) for chronic lymphocytic leukemia (CLL): results in 107 patients [abstract]","volume":"94","author":"Montserrat","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.leu.2402530","article-title":"Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia","volume":"16","author":"Dreger","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2004.04.005_BIB16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.bmt.1700914","article-title":"Combined positive\/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL","volume":"20","author":"Paulus","year":"1997","journal-title":"Bone Marrow Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.04.005_BIB17","article-title":"Outcome following autologous and allogeneic stem cell transplantation in chronic lymphocytic leukemia [abstract]","volume":"102","author":"Gribben","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.bmt.1701503","article-title":"PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia","volume":"22","author":"Scime","year":"1998","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hoc.2004.04.005_BIB19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2141.1997.1062924.x","article-title":"In vivo \u201cpurging\u201d of residual disease in CLL with Campath-1H","volume":"97","author":"Dyer","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2004.04.005_BIB20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/sj.leu.2401201","article-title":"Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia","volume":"12","author":"Sutton","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2004.04.005_BIB21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1008474526373","article-title":"High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic leukemia","volume":"9","author":"Pavletic","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2004.04.005_BIB22","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1182\/blood-2003-05-1549","article-title":"The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status","volume":"103","author":"Dreger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB23","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood-2002-06-1744","article-title":"Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia","volume":"101","author":"Ritgen","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.04.005_BIB24","first-page":"S33","article-title":"Allo and autotransplants in CLL","author":"Michallet","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hoc.2004.04.005_BIB25","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","article-title":"Eradication of polymerase chain reaction detectable chronic lymphocytic leukemia cells with improved outcome after bone marrow transplantation","volume":"88","author":"Provan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2402036","article-title":"Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status","volume":"15","author":"Esteve","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2004.04.005_BIB27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V98.1.29","article-title":"Quantitation of minimal residual disease in chronic lymphocytic leukaemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimise therapy","volume":"98","author":"Rawstron","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB28","unstructured":"Stilgenbauer S., Ritgen M., Bullinger L., Krober A., Lichter P., Dreger P., et al. Genomic aberrations in the CLL3 trial of the German CLL Study Group: deletion 11q23 identifies patients with molecular disease persistence after autologous high dose therapy. Blood 2001;98:763a\u20134"},{"key":"10.1016\/j.hoc.2004.04.005_BIB29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood-2002-03-0892","article-title":"Inherited predisposition to CLL is detectable as sub-clinical monoclonal B-lymphocyte expansion","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","article-title":"Monoclonal B lymphocytes with the characteristics of \u201cindolent\u201d chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB31","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5\u2212 B lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bmt.1702237","article-title":"Outcome of allogeneic s-c-t for B cell CLL","volume":"25","author":"Pavletic","year":"2000","journal-title":"Bone Marrow Tranpl"},{"key":"10.1016\/j.hoc.2004.04.005_BIB33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.leu.2402905","article-title":"Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning","volume":"17","author":"Dreger","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2004.04.005_BIB34","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: The Cooperative German Transplant Study Group","volume":"21","author":"Schetelig","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.04.005_BIB35","first-page":"197a","article-title":"Reduced-intensity conditioning lowers treatment-related mortality (TRM) of allogeneic stem cell transplantation (SCT) for CLL: a retrospective study of 448 patients","volume":"102","author":"Dreger","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.04.005_BIB36","first-page":"476a","article-title":"Results of allogeneic transplantation using fully myeloablative preparation in patients who are candidates for reduced intensity regimens","volume":"102","author":"Copeland","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB37","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1182\/blood.V89.11.3967","article-title":"Rapid engraftment without significant GVHD after allogeneic transplantation of CD34-positive selected cells from peripheral blood","volume":"89","author":"Urbano-Ispizua","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2004.04.005_BIB38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2141.1997.272673.x","article-title":"Allogeneic blood or bone marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease","volume":"97","author":"Khouri","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2004.04.005_BIB39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-124-3-199602010-00005","article-title":"HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia","volume":"124","author":"Michallet","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2004.04.005_BIB40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bmt.1703548","article-title":"Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia","volume":"29","author":"Doney","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2004.04.005_BIB41","first-page":"669","article-title":"Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"18","author":"Rondon","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hoc.2004.04.005_BIB42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.leu.2401669","article-title":"Minimal residual disease is common after allogeneic stem-cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host-disease","volume":"14","author":"Mattsson","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2004.04.005_BIB43","first-page":"371","article-title":"Clinical and hematological response of chronic lymphocytic leukemia and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia","volume":"17","author":"Mehta","year":"1996","journal-title":"Bone Marrow Transpl"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858804000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858804000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:36:44Z","timestamp":1760182604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858804000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0889858804000395"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2004.04.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of auto- and allotransplantation in B-cell chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2004.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}